Incidence, Risk Factors and Mortality of COVID-19 among Cancer Patients: A Meta-Analysis

Ahmad Fadhil Kombo, Xin-Ying Ji
{"title":"Incidence, Risk Factors and Mortality of COVID-19 among Cancer Patients: A Meta-Analysis","authors":"Ahmad Fadhil Kombo, Xin-Ying Ji","doi":"10.36349/easjms.2024.v06i06.001","DOIUrl":null,"url":null,"abstract":"Cancer is among the fatal diseases caused by abnormal cell growth from one organ that can invade and destroy adjacent organs. These abnormally growing cells are caused by defects in the gene sequence of the living organisms. These unregulated, proliferating cells exceed their normal boundaries to infiltrate adjacent bodily tissues and/or move to other organs. Cancer is the second leading cause of death globally, responsible for more than 10 million deaths in 2020 alone. Cancer is the second most common non-communicable disease to cause death. Currently, the health systems around the world are facing a huge challenge in finding a proper cure for cancer. Lung cancer is the leading cause of cancer deaths in China, followed by liver cancer, stomach cancer, esophageal cancer, and cardiovascular disorders, which together account for 43% of all deaths. Currently; the health system is facing huge challenge on the proper cure for cancer. This is because cancer is not one disease but many disorders that share a profound growth dysregulation of cells. The peculiar traits of cancer, including altered cellular metabolism, unlimited capacity for replication, sustained angiogenesis, the ability to invade and metastasize, the ability to evade apoptosis, self-sufficiency in growth signals, evasion of immune surveillance, and insensitivity to growth-inhibitory signals, are to chastise for this growth dysregulation. Due to their poor general health, concurrent illnesses, a systemic immunosuppressive condition brought on by cancer itself, and some drugs as conventional immune checkpoint inhibitors (ICIs) used to treat cancer, cancer patients are more vulnerable to different infectious diseases. Hence, cancer patients are more vulnerable to coronavirus infection. The main goal of this study was to conduct a meta-analysis of COVID-19 incidence, risk factors, and mortality among diverse cancer patients. We narrowed our attention to both inpatients and outpatients with Covid-19 symptoms du","PeriodicalId":446681,"journal":{"name":"EAS Journal of Medicine and Surgery","volume":"45 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EAS Journal of Medicine and Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36349/easjms.2024.v06i06.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer is among the fatal diseases caused by abnormal cell growth from one organ that can invade and destroy adjacent organs. These abnormally growing cells are caused by defects in the gene sequence of the living organisms. These unregulated, proliferating cells exceed their normal boundaries to infiltrate adjacent bodily tissues and/or move to other organs. Cancer is the second leading cause of death globally, responsible for more than 10 million deaths in 2020 alone. Cancer is the second most common non-communicable disease to cause death. Currently, the health systems around the world are facing a huge challenge in finding a proper cure for cancer. Lung cancer is the leading cause of cancer deaths in China, followed by liver cancer, stomach cancer, esophageal cancer, and cardiovascular disorders, which together account for 43% of all deaths. Currently; the health system is facing huge challenge on the proper cure for cancer. This is because cancer is not one disease but many disorders that share a profound growth dysregulation of cells. The peculiar traits of cancer, including altered cellular metabolism, unlimited capacity for replication, sustained angiogenesis, the ability to invade and metastasize, the ability to evade apoptosis, self-sufficiency in growth signals, evasion of immune surveillance, and insensitivity to growth-inhibitory signals, are to chastise for this growth dysregulation. Due to their poor general health, concurrent illnesses, a systemic immunosuppressive condition brought on by cancer itself, and some drugs as conventional immune checkpoint inhibitors (ICIs) used to treat cancer, cancer patients are more vulnerable to different infectious diseases. Hence, cancer patients are more vulnerable to coronavirus infection. The main goal of this study was to conduct a meta-analysis of COVID-19 incidence, risk factors, and mortality among diverse cancer patients. We narrowed our attention to both inpatients and outpatients with Covid-19 symptoms du
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症患者 COVID-19 的发病率、风险因素和死亡率:元分析
癌症是一种致命疾病,由一个器官中异常生长的细胞侵入并破坏邻近器官引起。这些异常生长的细胞是由生物体基因序列缺陷引起的。这些不受调控的增殖细胞会超出正常边界,渗透到邻近的身体组织和/或转移到其他器官。癌症是全球第二大死因,仅在 2020 年就有超过 1,000 万人死于癌症。癌症是导致死亡的第二大非传染性疾病。目前,世界各地的卫生系统在寻找适当的癌症治疗方法方面正面临着巨大挑战。肺癌是中国癌症死亡的首要原因,其次是肝癌、胃癌、食道癌和心血管疾病,这些疾病共占癌症死亡总数的 43%。目前,卫生系统在正确治疗癌症方面面临巨大挑战。这是因为癌症并不是一种疾病,而是多种疾病,它们都有严重的细胞生长失调。癌症的特殊性,包括细胞新陈代谢的改变、无限的复制能力、持续的血管生成、入侵和转移的能力、逃避细胞凋亡的能力、生长信号的自给自足、逃避免疫监视以及对生长抑制信号的不敏感,都是这种生长失调的罪魁祸首。由于癌症患者的总体健康状况较差、同时患有多种疾病、癌症本身带来的全身免疫抑制状态,以及一些用于治疗癌症的常规免疫检查点抑制剂(ICIs)药物,他们更容易感染各种传染性疾病。因此,癌症患者更容易感染冠状病毒。本研究的主要目的是对不同癌症患者的 COVID-19 发病率、风险因素和死亡率进行荟萃分析。我们将研究范围缩小到了有 Covid-19 症状的住院病人和门诊病人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Bacteremias in Intensive Care Unit: A Two-Year Retrospective Study Early Puerperium Gangrenous Sigmoid Volvulus: Case Report Respiratory Distress in Children Aged 6 to 59 Months at the Pediatric Department of the Csref of Commune V of Bamako: Clinical and Therapeutic Aspects Incidence, Risk Factors and Mortality of COVID-19 among Cancer Patients: A Meta-Analysis Heartache to Happiness: Managing a Six Year Hormonal Subfertility with a Successful Rate of Conception
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1